Metraipolis › archive › dc_18b4aa2cf50a

Dapagliflozin-Induced Dermatological Condition: Sweet's Syndrome — Europe PMC PMID:42437235

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42437235
DOI
10.7759/cureus.110647
License (as archived)
solo-consultazione
Archived
2026-10-31T14:15:52.379Z
SHA-256 of the archived text
c5b6c367e2c0a24f9308dbdda9fe5ab1c771373db5cd39caf188c1bb9eb03bec
Stable URL of this page
https://metraipolis.com/documento/dc_18b4aa2cf50a

How to cite

Dapagliflozin-Induced Dermatological Condition: Sweet's Syndrome — Europe PMC PMID:42437235 — Europe PMC (en), https://europepmc.org/article/MED/42437235 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_18b4aa2cf50a (Metraipolis archive dc_18b4aa2cf50a, sha256 c5b6c367e2c0a24f9308dbdda9fe5ab1c771373db5cd39caf188c1bb9eb03bec)
BibTeX
@misc{dc18b4aa2cf50a,
  title = {Dapagliflozin-Induced Dermatological Condition: Sweet's Syndrome — Europe PMC PMID:42437235},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42437235},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_18b4aa2cf50a; sha256 c5b6c367e2c0a24f9308dbdda9fe5ab1c771373db5cd39caf188c1bb9eb03bec},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42437235. Agents can read the archived copy with the MCP tool read_document.